| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.46 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |